Additional Description

Possible applications of Denosyl SD4 as adjunct therapy could include dogs and cats with elevated liver enzymes and suffering from: hepatic lipidosis, breed-specific chronic hepatitis, feline liver disease, Cushing's Disease, Inflammatory Bowel Disease, Pancreatitis, etc. Denosyl SD4 is available in three sizes: 30 tablets, 90 mg each for cats and small dogs and 30 tablets, 225 mg each for dogs over 25 lbs, and 425 mg. for larger dogs. * Denosyl SD4, a pure, patented, uniform, bioavailable, and stable salt of S-Adenosylmethionine * The only S-Adenosylmethionine brand studied in U.S. veterinary trials * Manufactured to Good Manufacturing Practice (GMP) standards * Enteric coated and blister packed tablets to avoid exposure to air * Supplied by the manufacturers of Cosequin® Denosyl SD4 has been shown to increase hepatic glutathione levels in cats and dogs. Glutathione, a potent antioxidant, is the liver's main detoxifier that protects hepatic cells from toxins and death. A recent analysis of 31 dogs and cats with various severe liver problems showed that 45% of these animals had low hepatic glutathione levels. Denosyl SD4 is recommended to improve hepatic glutathione levels in compromised patients to help maintain and protect liver function. Denosyl SD4 may also be used in other conditions of tissue oxidant injury and RBC fragility caused by certain toxins or drugs which are related to reduced glutathione concentrations.

Description provided by the manufacturer or retailer